Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response

A major barrier to successful antitumor vaccination is tolerance of high-avidity T cells specific to tumor antigens. In keeping with this notion, HER-2/neu (neu)-targeted vaccines, which raise strong CD8(+) T cell responses to a dominant peptide (RNEU(420-429)) in WT FVB/N mice and protect them from...

Descripción completa

Detalles Bibliográficos
Autores principales: Ercolini, Anne M., Ladle, Brian H., Manning, Elizabeth A., Pfannenstiel, Lukas W., Armstrong, Todd D., Machiels, Jean-Pascal H., Bieler, Joan G., Emens, Leisha A., Reilly, R. Todd, Jaffee, Elizabeth M.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2005
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212915/
https://www.ncbi.nlm.nih.gov/pubmed/15883172
http://dx.doi.org/10.1084/jem.20042167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212915/
https://www.ncbi.nlm.nih.gov/pubmed/15883172
http://dx.doi.org/10.1084/jem.20042167

Ejemplares similares